Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Jump to: Article
Number of items: 5.
Article
Biswas, Dhruva;
Kanu, Nnennaya;
Swanton, Charles;
(2025)
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
adenocarcinoma.
Nature Cancer
10.1038/s43018-024-00883-1.
(In press).
|
|
Bogani, G;
Moore, KN;
Ray-Coquard, I;
Lorusso, D;
Matulonis, UA;
Ledermann, JA;
González-Martín, A;
... Monk, BJ; + view all
(2025)
Incorporating immune checkpoint inhibitors in epithelial ovarian cancer.
Gynecologic Oncology
, 193
pp. 30-40.
10.1016/j.ygyno.2024.12.011.
|
|
Francis, Katherine E;
Simon, Sandy;
Gebski, Val;
Joly, Florence;
Ledermann, Jonathan A;
Penson, Richard T;
Oza, Amit M;
... Lee, Chee Khoon; + view all
(2025)
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.
Gynecologic Oncology
, 192
pp. 50-55.
10.1016/j.ygyno.2024.11.004.
(In press).
|
|
Mears, HV;
Young, GR;
Sanderson, T;
Harvey, R;
Barrett-Rodger, J;
Penn, R;
Cowton, V;
... Bauer, DLV; + view all
(2025)
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
PLoS Biology
, 23
(1)
, Article e3002982. 10.1371/journal.pbio.3002982.
|
 |
|
Pawsey, A;
Mahalingam, P;
Senthivel, N;
Ramessur, A;
Turnbull, E;
Usman, S;
Browne, R;
... Eminowicz, G; + view all
(2025)
Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.
Clinical Oncology
, 37
, Article 103656. 10.1016/j.clon.2024.10.008.
|
